| Name | Title | Contact Details |
|---|
Metamark Genetics, Inc. is a privately held biotechnology company founded in 2007 to develop novel, function-based, prognostic and diagnostic tests aimed at improving cancer care. The company's proprietary genomic and proteomic discovery platforms have yielded significant discoveries in several disease areas, including prostate, colon, and breast cancers. In early 2014, Metamark plans to commercialize ProMark™—its prostate cancer prognostic test—through its Cambridge, Massachusetts CLIA-certified laboratory. For more information, please visit the company's Website at www.metamarkgenetics.com. Metamark™ and ProMark™ are trademarks of Metamark Genetics, Inc.
Metropolitan Health Networks, Inc. is a West Palm Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
St Vincent Infirmary Medical Center is a Little Rock, AR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
PDI Inc. is a provider of contract sales teams to pharmaceutical companies, offering a range of sales support services.
HT Systems is a Lutz, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.